Jeff Yass’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.9K Sell
2,913
-1,160
-28% -$30.3K ﹤0.01% 12691
2026
Q1
$127K Sell
4,073
-340
-8% -$11.5K ﹤0.01% 12168
2025
Q4
$138K Sell
4,413
-247
-5% -$8.11K ﹤0.01% 11244
2025
Q3
$134K Buy
4,660
+1,672
+56% +$303K ﹤0.01% 11369
2025
Q2
$606K Buy
2,988
+885
+42% +$139K ﹤0.01% 8730
2025
Q1
$254K Buy
2,103
+1,830
+670% +$267K ﹤0.01% 10436
2024
Q4
$39.5K Buy
+273
New +$33.1K ﹤0.01% 11768
2023
Q3
– Sell
-1,378
Closed -$119K – 13170
2023
Q2
$119K Buy
+1,378
New +$120K ﹤0.01% 10805
2022
Q4
– Sell
-2,460
Closed -$295K – 13887
2022
Q3
$295K Sell
2,460
-283
-10% -$37.9K ﹤0.01% 9839
2022
Q2
$310K Buy
2,743
+65
+2% +$9.4K ﹤0.01% 9485
2022
Q1
$573K Buy
2,678
+1,923
+255% +$436K ﹤0.01% 8627
2021
Q4
$226K Sell
755
-338
-31% -$113K ﹤0.01% 11191
2021
Q3
$397K Buy
+1,093
New +$262K ﹤0.01% 9962

Other funds holding ATYR

Jeff Yass's ATYR Position: Q2 2026 in Review

Jeff Yass reduced its aTyr Pharma (ATYR) stake by 14% in Q2 2026, selling an estimated $78.2K and leaving 18,676 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #10172.

Jeff Yass first reported a position in ATYR in Q1 2017 and has held it in 17 quarters since. The position peaked at $5.23M in Q1 2025. 87 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Jeff Yass held 18,676 shares of aTyr Pharma worth $446K as of Q2 2026.
  • Jeff Yass sold 2,993 aTyr Pharma shares in Q2 2026, an estimated $78.2K.
  • aTyr Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10172 holding.
  • Jeff Yass first reported a position in aTyr Pharma in Q1 2017 and has held it in 17 quarters since.
  • Jeff Yass's aTyr Pharma position peaked at $5.23M in Q1 2025.
  • 87 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.